UAE Plasmid Dna Contract Manufacturing Market Size & Outlook
UAE plasmid dna contract manufacturing market, 2018-2030 (US$M)
Related Markets
UAE plasmid dna contract manufacturing market highlights
- The UAE plasmid dna contract manufacturing market generated a revenue of USD 2.2 million in 2023 and is expected to reach USD 7.7 million by 2030.
- The UAE market is expected to grow at a CAGR of 19.4% from 2024 to 2030.
- In terms of segment, cell & gene therapy was the largest revenue generating application in 2023.
- Cell & Gene Therapy is the most lucrative application segment registering the fastest growth during the forecast period.
Plasmid dna contract manufacturing market data book summary
| Market revenue in 2023 | USD 2.2 million |
| Market revenue in 2030 | USD 7.7 million |
| Growth rate | 19.4% (CAGR from 2023 to 2030) |
| Largest segment | Cell & gene therapy |
| Fastest growing segment | Cell & Gene Therapy |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cell & Gene Therapy, Immunotherapy |
| Key market players worldwide | Charles River Laboratories International Inc, Boehringer Ingelheim, Thermo Fisher Scientific Inc, Lonza Group Ltd, Viva Biotech, VGXI, PlasmidFactory, BioCina, TriLink BioTechnologies, Esco Aster |
Other key industry trends
- In terms of revenue, UAE accounted for 0.7% of the global plasmid dna contract manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa plasmid dna contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 7.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Plasmid DNA Contract Manufacturing Market Scope
Plasmid DNA Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE plasmid dna contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna contract manufacturing market will help companies and investors design strategic landscapes.
Cell & gene therapy was the largest segment with a revenue share of 63.64% in 2023. Horizon Databook has segmented the UAE plasmid dna contract manufacturing market based on cell & gene therapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
The rising number of cancer cases, growing popularity of gene therapy, and rising government & private expenditure on the healthcare sector are the key factors driving the market growth in the country. UAE is one of the fastest-growing economies with a constant increase in noncommunicable diseases, including cancer.
According to the International Agency for Research on Cancer, cancer incidence in the age group of 20 to 49 years was 45.4% in 2020. A majority of the population of the UAE is younger as compared to other countries around the globe. The figure below shows a comparison of the incidence of cancer in different countries in the year 2020 in the age group of 20 to 49 years.
Reasons to subscribe to UAE plasmid dna contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE plasmid dna contract manufacturing market databook
-
Our clientele includes a mix of plasmid dna contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE plasmid dna contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into UAE plasmid dna contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE plasmid dna contract manufacturing market size, by application, 2018-2030 (US$M)
UAE Plasmid DNA Contract Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
